Search Results
Found 710 results for "pharmaceuticals" across articles, medicines, trials, companies and the glossary
MedicinesAll 666 →
Abecma 260 - 500 x 106 cells dispersion for infusionIdecabtagene Vicleucel · Bristol-Myers Squibb Pharmaceuticals uc
Abiraterone Mylan 1000 mg film-coated tabletsAbiraterone acetate · Mylan Pharmaceuticals Limited
Abiraterone Mylan 500 mg film-coated tabletsAbiraterone acetate · Mylan Pharmaceuticals Limited
Abiraterone Rowa 500 mg Film-coated tabletsAbiraterone acetate · Rowa Pharmaceuticals Limited,
Aclasta 5 mg solution for infusionZoledronic acid · Sandoz Pharmaceuticals d.d.
Adizem-SR 120 mg Prolonged Release CapsulesDiltiazem hydrochloride · Mundipharma Pharmaceuticals Limited
Clinical trials in IrelandTracker →
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Pat…Active · Jazz Pharmaceuticals
FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics o…Active · Ionis Pharmaceuticals, Inc.
A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral …Active · Novartis Pharmaceuticals
Industry
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
A comprehensive guide to utilizing Priya Life Science's live trackers. Learn how to track clinical trials, regulatory recalls, drug shortages, biotech layoffs, and M&A venture activity to accelerate your career and optimize market intelligence.
Industry
Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
An in-depth analysis of Ireland's €93.8 billion pharmaceutical and medical exports to non-EU markets. Examining trade data across the United States, UK, Switzerland, and Asia-Pacific, key manufacturing clusters in Cork, Dublin, and Limerick, and the strategic outlook for 2026.
Industry
Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Global equity markets open August 2026 on a historic high as rumored $400B AstraZeneca-BMS merger talks and Curium's $8B Lantheus acquisition spark a massive biopharmaceutical consolidation wave.
Industry
Trump’s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications
An in-depth evaluation of Donald Trump’s scheduled September visit to Ireland, examining the Doonbeg Irish Open itinerary, security logistics, protectionist tariffs, corporate tax policy friction, and strategic implications for U.S.-Irish bilateral relations.
Industry
The Cost-Governed Enterprise: A Financial Governance Playbook for AI in Irish Life Sciences
MIT research found that 95% of enterprise generative AI pilots show no measurable P&L impact, despite up to €36.8bn of global investment. The failure is not the technology, it is governance: cost is billed and legible, return is diffuse and uninstrumented. A seven-band cost taxonomy, eight load-bearing equations and the make-versus-rent crossover that Irish life sciences boards need to close the gap.
Industry
AI in Pharma H1 2026 Report: Mega-Deals, On-Premise Supercomputer Factories, and Clinical Translation Milestones
A comprehensive half-year update on artificial intelligence in pharmaceutical drug discovery, detailing Isomorphic's $2.1B Series B, Insilico's multi-billion partnerships, NVIDIA's private AI factories, and Phase I/II clinical pipeline progress.
Industry
US Pharmaceutical Tariffs Update: Policy Realities, The Stockpile 'Unwind', and Ireland’s Strategic Position
An in-depth analysis of where US pharmaceutical tariff policies stand in mid-2026 under the Trump administration, analyzing recent CSO export data, inventory stockpiling corrections, MFN agreements, and Ireland’s strategic biopharma position.
Industry
High Expectations, Historic Opportunity: What Ireland’s Rotating EU Council Presidency Can Deliver for European and Irish Pharma
A Priya Life Science White Paper analyzing the pivotal policy dossiers of the 2026 Irish Presidency, the economic stakes for biopharma manufacturing, and key strategic recommendations.
Industry
Quantum 2030: How Ireland’s New Strategic Blueprint Aims to Secure Global Leadership in Quantum Computing
The Irish Government launches "Quantum 2030", a whole-of-government national strategy designed to position Ireland as an internationally competitive hub in quantum technologies, research, and talent by 2030.
Industry
GEODIS Expands European Logistics Network with 2,000-Pallet Temperature-Controlled Manchester Pharma Hub
GEODIS opens a state-of-the-art GDP-compliant pharmaceutical hub in Sharston Green, South Manchester, offering 2,000 pallet positions, 15-25°C and 2-8°C climate-controlled storage, and direct air/sea connectivity to Ireland and global markets.
Biotechnology
Ireland's Biopharma Manufacturing Hub: A Master Guide to Tax, Talent, CDMO Sourcing, and Regulatory Excellence
An in-depth analysis of Ireland's evolution into Europe's second-largest exporter of medicinal products. Discover how a 12.5% tax structure, NIBRT bioprocessing excellence, HPRA regulatory trust, and a thriving CDMO ecosystem make Ireland the premier location for global drug production.
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
Biotechnology
Bilateral Breakthrough: How the Historic UK-India Free Trade Agreement Transforms Life Sciences and Key Trade Sectors
The historic UK-India Comprehensive Economic and Trade Agreement (CETA) and Double Contributions Convention have officially entered into force, opening duty-free access for pharmaceuticals, dismantling high tariffs on manufacturing inputs, and eliminating dual social security taxes for mobile professionals.
Industry
Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026
Chanelle Pharma has confirmed the renewal of its long-standing partnership with the Galway Races Summer Festival for 2026, marking 41 consecutive years of sponsoring the prestigious Leading Trainer Award alongside the Best Turned Out Series.
Industry
The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape
Ireland's contract manufacturing exports-colloquially known as "phantom exports"-are surging once again, raising fresh questions about the decoupling of headline economic figures from the domestic life sciences economy.
Biotechnology
The Dublin-Backed Roll-Up Reshaping UK Pharma Packaging: Inside Woodberry's Double Acquisition
In a deal announced on July 7, 2026, Woodberry Packaging - the Dublin-backed packaging group led by veteran entrepreneur Patrick Doran - has acquired Medica Packaging, the UK's largest independent pharmaceutical carton converter, and F.G. Curtis, a respected name in cosmetics and personal care packaging. The combined group now employs 650 people across the UK and Ireland with revenues exceeding €120 million, marking a significant consolidation moment in the specialist packaging sector.
Regulatory Affairs
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals
In a landmark world-first, Irish-founded Chanelle McCoy Health has received official regulatory approvals from the Saudi Food and Drug Authority and confirmation of safety under EU Novel Food guidelines for its Pureis® Ultra Pure CBD range.
Pharmaceutical
Cold Chain Management and Good Distribution Practice (GDP) for Biologics and Vaccines
An academic analysis of temperature-sensitive supply chains, GDP compliance, distribution monitoring, and shipping deviation management.
Pharmaceutical
An Introduction to Lyophilization (Freeze-Drying) Technology and Cycle Development in Biopharma
An academic analysis of the freeze-drying process, sublimation phases, critical chamber controls, and lyophilized formulation parameters.
Biotechnology
From Farming to Pharma: The History of Ireland’s Life Sciences Revolution
How did a nation once defined by agriculture and emigration transform into the world’s third-largest exporter of pharmaceuticals? We trace the deliberate policy shifts, educational reforms, and FDI strategies that built Ireland’s booming life sciences ecosystem.
Industry
Navigating Ireland’s Pharma Dependency: Strategies for Policy and Talent in an Uncertain Era
With pharmaceuticals making up 20% of Ireland’s GDP, the nation’s reliance on the industry brings immense economic benefit but notable risks. We explore how Ireland must adapt its policy, manage geopolitical headwinds, and aggressively attract skilled labour to secure its future.
Industry
Egypt, Ireland Explore Industrial Cooperation in Pharmaceuticals, Renewable Energy, and Advanced Technologies
Egypt’s Minister of Industry and Ireland’s Ambassador discuss strategic collaboration across pharmaceuticals, renewable energy, and technology sectors, aiming to leverage Irish expertise for local manufacturing.
Clinical Trials
The 2026 Obesity Power Rankings: Which Pharma Giants Can Break the Lilly-Novo Duopoly?
With the obesity market projected to exceed $130 billion by 2034, we analyze the top 10 pharmaceutical companies vying for dominance. Explore our comprehensive Power Rankings assessing pipeline depth, clinical differentiation, and commercial infrastructure.
Biotechnology
A Biotech Buying Frenzy: Inside the H1 2026 Pharma M&A Surge
An in-depth analysis of the massive wave of pharmaceutical mergers and acquisitions in the first half of 2026, driven by patent cliffs, pipeline replenishment, and high-growth therapeutic areas.
Pharmaceutical
The Innovation Exodus: Why Europe Must Rethink Medicine Pricing or Risk Losing Life Science Investments
An in-depth analysis of the warnings from pharmaceutical lobby chief Stefan Oelrich regarding European cost-cutting reforms, global pricing shifts, and the threat to clinical research and manufacturing.
Industry
U.S. Initiates Tariff Probe into Germany’s Pharmaceutical Pricing Policies
The United States has formally launched a trade investigation under Section 301 into Germany’s drug reimbursement practices, citing concerns that domestic price controls unfairly burden American innovation.
Industry
Jazz Pharmaceuticals Strikes Strategic $820M Research Deal with AbCellera for Next-Gen T-Cell Engaging Antibodies
Discover how Jazz Pharmaceuticals and AbCellera are joining forces in a high-stakes, $820M biopharma collaboration to pioneer next-generation T-cell engaging (TCE) multispecific antibodies targeting gastrointestinal cancers and challenging solid tumors.
Pharmaceutical
Leading CDMO Companies in Ireland: Your Complete Guide to Contract Manufacturing in 2026
A comprehensive guide to the top CDMO companies in Ireland - from Hovione and Thermo Fisher in Cork to EirGen Pharma in Waterford and HiTech Health in Galway. Full profiles, capabilities, certifications, and facilities of Ireland's leading contract development and manufacturing organizations.
Clinical Trials
Navigating Challenges in Oncology: Jazz Pharmaceuticals and PharmaMar Stay Committed Despite Phase 3 Setback
In the rigorous and highly demanding landscape of oncology research, scientific progress is often non-linear. Recently, Jazz Pharmaceuticals and its partner PharmaMar announced that their Phase 3 trial evaluating Zepzelca did not meet its primary endpoint.
MedTech
EU-India FTA: A New Era of Trade Creating a 2 Billion People Free Trade Zone
Discover how the monumental EU-India Free Trade Agreement creates a market of 2 billion people. Explore its impact on tech, education, and how it will specifically propel Ireland's pharmaceutical and life sciences sector.
MedTech
A Tale of Two Systems: Why US Healthcare Costs are Skyrocketing and What it Means for Ireland
A recent PwC report warns that US commercial healthcare costs will surge by 9% in 2027. We compare the driving forces behind this unprecedented American inflation with the pressures currently facing the Irish healthcare system.
MedTech
Emerging Pharma Companies in Ireland to Watch in 2026
Discover the top 5 high-growth Irish life science, biotech, and medtech companies transforming the healthcare landscape. From Enterprise Ireland backed startups to global scale-ups, these are the emerging leaders of 2026.
MedTech
The Digital-First Regulatory Landscape: How Ireland's Life Science Sector Is Adapting to the EU AI Act, EHDS, and Governance by Design
A comprehensive guide for Irish pharmaceutical, MedTech, and life science professionals on the EU AI Act implementation, the European Health Data Space, cGMP compliance in an AI-driven environment, ALCOA+ in digital systems, and the practical steps organisations must take to achieve governance by design in 2026.
Pharmaceutical
Why Ireland Remains the Global Pharma Hub: Analyzing the Historic $6.6 Billion Eli Lilly Tax Disclosure
The June 2026 country-by-country disclosures revealed that Eli Lilly paid $6.6 billion in Irish corporation tax-double its US federal liability. We analyze why Ireland remains the ultimate hub for global pharma despite the OECD 15% minimum tax.
Pharmaceutical
How the Iran Conflict Is Disrupting Ireland’s Pharmaceutical Industry and Why It Matters Globally.
Middle East air route disruptions are raising costs and delaying Ireland’s pharma exports, impacting global medicine supply chains.
Pharmaceutical
Ireland’s Pharmaceutical Export Decline in 2026: A Data-Driven Analysis of Emerging Trade Shifts
Ireland’s pharma exports fell 35% in Jan 2026, driven by a sharp decline in US shipments. Explore causes, trends, and global life sciences impact.
Regulatory Affairs
The New Frontier in Pharma: Plant-Derived Cannabinoid APIs
Cannabinoid APIs are transforming pharma with precise, plant-derived medicines, balancing sustainability, regulation, and innovation.